The cases from Joye et al. demonstrated complexity—one patient had an underlying MC4R mutation leading to left heart disease with persistent PH progression, while the second (biliary atresia) showed clinical improvement but residual PAH on triple therapy. This evidence concerns the gene MC4R and pulmonary arterial hypertension.